Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Half Yearly Report

27 Sep 2010 07:00

RNS Number : 3151T
X-Phonics plc
27 September 2010
 



X-PHONICS PLC

("X-Phonics" or the "Company")

 

Interim Statement for the period ended 31st March 2010

 

CHAIRMAN'S STATEMENT

 

I present the financial statements for the six months to 31st March 2010.

 

Over the last six months we have continued to seek alternative opportunities that could make use of the company's infrastructure and listing on AIM in market sectors where there is scale, growth and a revenue model that is better suited to a public market.

 

Having looked at a number of possible opportunities I am pleased to be able to tell you that the Company announced on 3rd September proposals for a proposed investment through Verdes Management Limited ("VML") to raise £141,000 in aggregate (before expenses), Board changes and a strategic change in business direction for the Company conditional upon a share reorganisation and shareholders' approval in general meeting.

 

The investing policy of the Group (subject to shareholders' approval) will be to pursue a new strategic business direction as a turnaround advisory business offering services to stakeholders, as well as seeking investment opportunities in UK public companies in need of restructuring.

 

The net proceeds of the fundraising through VML will provide short term working capital to allow the Company to commence business, and progress the proposed recruitment of an established turnaround team (where discussions are currently at an advanced stage). It is intended that there will be a more substantial fundraising in due course.

 

I hope to be able to report progress upon this matter in due course.

 

Robin Davies

Chairman

27 September 2010

 

Contacts:

X-Phonics plc

www.xphonicsgroup.co.uk

Mike Hosie, Finance Director

+44 (0) 208 987 0800

WH Ireland Limited

www.wh-ireland.co.uk

John Wakefield / Marc Davies

+44 (0) 117 945 3470

 

X-Phonics plc

Consolidated Income Statement for six months ended 31st March 2010

 

Note

6 months ended

31 March 2010

6 months ended

31 March 2009

Year ended

30 September 2009

(unaudited)

(unaudited)

(audited)

£

£

£

Revenue

34,364

67,712

94,066

Cost of Sales

-

(24,134)

(37,194)

Gross Profit

34,364

43,578

56,872

Administrative expenses

(50,432)

(82,077)

(154,722)

Operating Loss

(16,068)

(38,499)

(97,850)

Finance income

-

1

47

Finance costs

(218)

(221)

(546)

Loss on ordinary activities before taxation

(16,286)

(38,719)

(98,349)

Income tax expense

-

-

-

Loss for the period

(16,286)

(38,719)

(98,349)

Loss per share attributable to the equity holders of the company:

Basic loss per ordinary share

3.

(0.03 pence)

(0.06 pence)

(0.15 pence)

Diluted loss per ordinary share

3.

(0.03 pence)

(0.06 pence)

(0.15 pence)

 

All of the activities of the group are classed as continuing

 

X-Phonics plc

Consolidated Balance Sheet as at 31st March 2010

 

31 March 2010

31 March 2009

30 September 2009

(unaudited)

(unaudited)

(audited)

£

£

£

Assets

Non-current assets

Property, plant and equipment

8,158

27,120

17,460

8,158

27,120

17,460

Current assets

Trade and other receivables

54,381

77,777

49,328

Cash and cash equivalents

2,451

5,618

7,457

56,832

83,395

56,785

Total assets

64,990

110,515

74,245

Liabilities and Equity

Current liabilities

Trade and other payables

431,252

399,077

422,181

Financial liabilities - bank overdraft

-

-

1,148

Obligations under finance lease

4,091

5,875

4,983

Total liabilities

435,343

404,952

428,312

Equity

Called-up equity share capital

2,803,119

2,803,119

2,803,119

Share premium account

743,474

743,474

743,474

Merger reserve

(738,578)

(738,578)

(738,578)

Retained earnings

(3,178,368)

(3,102,452)

(3,162,082)

Total Equity

(370,353)

(294,437)

(354,067)

Total Liabilities and Equity

64,990

110,515

74,245

 

X-Phonics plc

Consolidated Statement of Changes in Equity as at 31st March 2010

 

Share Capital

Share Premium

Merger Reserve

Retained Earnings

Total Equity

£

£

£

£

£

 

Balance at 1 October 2008

2,803,119

743,474

(738,578)

(3,063,733)

(255,718)

Loss for period

-

-

-

(38,719)

(38,719)

At 31 March 2009

2,803,119

743,474

(738,578)

(3,102,452)

(294,437)

Loss for period

-

-

-

(59,630)

(59,630)

At 30 September 2009

2,803,119

743,474

(738,578)

(3,162,082)

(354,067)

Loss for period

-

-

-

(16,286)

(16,286)

At 31 March 2010

2,803,119

743,474

(738,578)

(3,178,368)

(370,353)

 

X-Phonics plc

Consolidated Cash Flow Statement for six months ended 31st March 2010

 

6 months ended

31 March 2010

6 months ended

31 March 2009

Year ended

30 September 2009

(unaudited)

(unaudited)

(audited)

£

£

£

Net cash (outflow)/inflow from operating activities

 

(2,749)

370

2,233

Investing activities

Interest paid

(218)

(221)

(546)

Interest received

-

1

47

Net cash flow before financing activities

(2,967)

150

1,734

Financing activities

Capital element of finance leases repaid

(891)

(891)

(1,784)

Net cash used in financing activities

(891)

(891)

(1,784)

Net (decrease)/increase in cash and cash equivalents

(3,858)

(741)

(50)

Opening net cash and cash equivalents

6,309

6,359

6,359

Closing net cash and cash equivalents

2,451

5,618

6,309

Reconciliation of operating loss to net cash outflow/inflow from operating activities

6 months ended

31 March 2010

6 months ended

31 March 2009

Year ended

30 September 2009

£

£

£

Operating Loss

(16,068)

(38,499)

(97,850)

Depreciation

9,301

9,661

19,322

Operating cash flows before movements in working capital

(6,767)

(28,838)

(78,528)

Decrease/(increase) in receivables

(5,053)

6,483

33,675

Increase/(decrease) in payables

9,071

22,725

45,829

Net movement in working capital

4,018

29,208

79,504

Net movement in cash flow

(2,749)

370

976

Income taxes paid

-

-

1,257

Net cash (outflow)/inflow from operating activities

(2,749)

370

2,233

 

Notes to the unaudited financial statements

 

1. Basis of prepapration
 
The financial information included in this report does not constitute statutory accounts as defined in section 435 of the Companies Act 2006. The consolidated interim financial statements for the six months ended 31 March 2010 have been prepared under applicable International Financial Reporting Standards adopted by the European Union ("IFRS").The financial information for the period ended 30 September 2009 has been extracted from the statutory accounts for that period. The auditors’ report on the full statutory accounts for the period ended 30 September 2009 was unqualified with an emphasis of matter with regards going concern. The financial information for the six months ended 31 March 2009 and 31 March 2010 has not been audited.

2. Principal Accounting Policies

 

The principal accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 September 2009 and are those expected to be applied for the year ended 30 September 2010. 

 

3. Earnings per Share

 

The earnings per ordinary share have been calculated on the ordinary activities after taxation of £16,286 (31 March 2009 - £38,719, 30 September 2009 - £98,349) using the weighted average number of ordinary shares in issue during the peiod being 66,214,920 (31 March 2009 - 66,214,920, 30 September 2009 - 66,214,920). The weighted average number of diluted ordinary shares in issue during the period was 66,214,920 (31 March 2009 - 66,214,920, 30 September 2009 - 66,214,920).

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR USSBRRNAKUAR
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.